A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins - PubMed (original) (raw)

. 2011 Aug 12;333(6044):850-6.

doi: 10.1126/science.1205669. Epub 2011 Jul 28.

Jarrod Voss, Steven J Gamblin, Giosiana Codoni, Annalisa Macagno, David Jarrossay, Sebastien G Vachieri, Debora Pinna, Andrea Minola, Fabrizia Vanzetta, Chiara Silacci, Blanca M Fernandez-Rodriguez, Gloria Agatic, Siro Bianchi, Isabella Giacchetto-Sasselli, Lesley Calder, Federica Sallusto, Patrick Collins, Lesley F Haire, Nigel Temperton, Johannes P M Langedijk, John J Skehel, Antonio Lanzavecchia

Affiliations

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

Davide Corti et al. Science. 2011.

Abstract

The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. Using a single-cell culture method for screening large numbers of human plasma cells, we isolated a neutralizing monoclonal antibody that recognized the hemagglutinin (HA) glycoprotein of all 16 subtypes and neutralized both group 1 and group 2 influenza A viruses. Passive transfer of this antibody conferred protection to mice and ferrets. Complexes with HAs from the group 1 H1 and the group 2 H3 subtypes analyzed by x-ray crystallography showed that the antibody bound to a conserved epitope in the F subdomain. This antibody may be used for passive protection and to inform vaccine design because of its broad specificity and neutralization potency.

PubMed Disclaimer

Comment in

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources